Free Trial

Treace Medical Concepts (TMCI) Insider Trading & Ownership

$5.68
+0.20 (+3.65%)
(As of 12:50 PM ET)

Treace Medical Concepts (NASDAQ:TMCI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.43%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$4.21 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get TMCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Treace Medical Concepts stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TMCI Insider Buying and Selling by Quarter

Treace Medical Concepts Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2024John T TreaceCEOBuy50,000$5.31$265,500.00  
8/15/2024James T TreaceDirectorBuy84,000$5.96$500,640.00  
8/14/2024John T TreaceCEOBuy85,000$6.00$510,000.00  
6/11/2024John T TreaceCEOBuy45,000$5.88$264,600.00  
5/31/2024James T TreaceDirectorBuy25,000$6.05$151,250.00  
5/28/2024James T TreaceDirectorBuy50,000$5.07$253,500.00  
This diversified cannabis pioneer could make huge moves soon (Ad)

The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers.

5/22/2024Richard W MottDirectorBuy12,100$4.99$60,379.00  
5/17/2024John T TreaceCEOBuy100,000$5.56$556,000.00  
5/13/2024John T TreaceCEOBuy150,000$4.56$684,000.00  
5/13/2024Richard W MottDirectorBuy36,802$4.38$161,192.76  
5/10/2024Deepti JainDirectorBuy25,000$4.50$112,500.00  
5/10/2024John T TreaceCEOBuy150,000$4.58$687,000.00  
(Data available from 1/1/2013 forward)

TMCI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Treace Medical Concepts includes Aaron Berutti, Daniel E Owens, Deepti Jain, F Barry Bays, James T Treace, John R Treace, John T Treace, Mark Hair, Richard W Mott, Scot Michael Elder, Sean F Scanlan, Terry W Lubben, and Thomas E Timbie. Learn more on insiders at TMCI.

24.43% of Treace Medical Concepts stock is owned by insiders. Learn more on TMCI's insider holdings.

The following insiders have purchased TMCI shares in the last 24 months: Aaron Berutti ($39,894.50), Deepti Jain ($112,500.00), James T Treace ($905,390.00), John T Treace ($3,511,250.00), and Richard W Mott ($221,571.76).

Insiders have purchased a total of 839,727 TMCI shares in the last 24 months for a total of $4,790,606.26 bought.

The following insiders have sold TMCI shares in the last 24 months: Aaron Berutti ($17,892.53), Daniel E Owens ($410,937.50), F Barry Bays ($34,904,015.80), James T Treace ($3,745,574.68), John T Treace ($50,650.75), Mark Hair ($25,386.40), Richard W Mott ($9,702,612.00), Scot Michael Elder ($14,380.98), Sean F Scanlan ($2,424,250.00), and Thomas E Timbie ($5,350,272.12).

Insiders have sold a total of 2,269,233 Treace Medical Concepts shares in the last 24 months for a total of $56,645,972.76 sold.



This page (NASDAQ:TMCI) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners